[Federal Register Volume 77, Number 122 (Monday, June 25, 2012)]
[Notices]
[Page 37909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-15431]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting: Board of Scientific Counselors, National Center for 
Injury Prevention and Control, Secondary Review

    The meeting announced below concerns, FOA CE12-004: Characterizing 
the Short and Long Term Consequences of Traumatic Brain Injury (TBI) 
among Children in the United States (U01); CE12-005: Field Triage of 
Traumatic Brain Injury (TBI) in Older Adults Taking Anticoagulants or 
Platelet Inhibitors (U01); CE12-006: Alcohol-related Motor Vehicle 
Injury Research (U01); and CE12-007: Research to Prevent Prescription 
Drug Overdoses (U01).
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 11 a.m.-1 p.m., July 12, 2012 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will conduct the secondary 
review, discussion of competitive applications following initial 
review of applications received in response to FOA CE12-004: 
Characterizing the Short and Long Term Consequences of Traumatic 
Brain Injury (TBI) among Children in the United States (U01); CE12-
005: Field Triage of Traumatic Brain Injury (TBI) in Older Adults 
Taking Anticoagulants or Platelet Inhibitors (U01); CE12-006: 
Alcohol-related Motor Vehicle Injury Research (U01); and CE12-007: 
Research to Prevent Prescription Drug Overdoses (U01).
    Contact Person for More Information: Gwendolyn Haile Cattledge, 
Ph.D., M.S.E.H., F.A.C.E., Deputy Associate Director for Science, 
CDC, 4770 Buford Highway, Atlanta, Georgia 30341, Telephone: (404) 
488-1430.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: June 19, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-15431 Filed 6-22-12; 8:45 am]
BILLING CODE 4163-18-P